RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of $101.00. The company’s shares closed yesterday at ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Globus Medical (GMED) reports results for the quarter ended December 2024. While this widely-known consensus ...

Morgan Stanley analyst Kallum Titchmarsh maintained a Buy rating on Globus Medical (GMED – Research Report) today and set a price target of $100.00. The company’s shares closed yesterday at ...

GMED opened at $77.48 on Wednesday. The firm has a 50 day moving average price of $85.90 and a 200-day moving average price of $79.63. Globus Medical has a twelve month low of $49.33 and a twelve ...

In trading on Tuesday, shares of Globus Medical Inc (Symbol: GMED) entered into oversold territory, hitting an RSI reading of 28.4, after changing hands as low as $78.6301 per share. By comparison ...

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Globus Medical (NYSE:GMED) and its peers. The medical ...

GMED opened at $80.43 on Monday. Globus Medical, Inc. has a fifty-two week low of $49.33 and a fifty-two week high of $94.93. The firm’s fifty day moving average price is $86.72 and its two ...